{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Urinary protein excretion was unaltered by rhIGF - I treatment in rats with chronic PAN nephropathy .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| chronic PAN nephropathy |\n\nExplanation:\n\n* \"chronic PAN nephropathy\" is a disease entity, as it refers to a specific kidney disease caused by the PAN (polyarteritis nodosa) condition."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| chronic PAN nephropathy |\n\nExplanation:\n\n* \"chronic PAN nephropathy\" is the only clear disease entity in the paragraph, as it refers to a specific kidney disease caused by the PAN (polyarteritis nodosa) condition.\n* \"urinary protein excretion\" and \"rhIGF-I treatment\" are not disease entities, but rather processes or treatments related to the disease."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Urinary protein excretion was unaltered by rhIGF - I treatment in rats with chronic PAN nephropathy .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| rhIGF - I |\n| PAN |\n\nIn this paragraph, the two chemical entities mentioned are \"rhIGF - I\" and \"PAN\". \"rhIGF - I\" refers to recombinant human Insulin-like Growth Factor I, while \"PAN\" stands for Puromycin Aminonucleoside, a compound commonly used to induce nephropathy in experimental animals."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| rhIGF - I |\n| PAN |\n\nIn this paragraph, the two chemical entities mentioned are \"rhIGF - I\" and \"PAN\". \"rhIGF - I\" refers to recombinant human Insulin-like Growth Factor I, while \"PAN\" stands for Puromycin Aminonucleoside, a compound commonly used to induce nephropathy in experimental animals. There are no chemical entities in the paragraph that do not clearly refer to chemicals."}
  ]
}